Monica Bhatia, MD – FDA 483, Jan 31, 2019
This FDA Form 483 was issued to Monica Bhatia, MD, a clinical investigator in New York, NY, following an inspection from January 28-31, 2019. The inspection revealed significant issues related to the conduct of clinical research, specifically concerning the timely reporting of study changes to the IRB and adherence to the investigational plan. These findings indicate a lack of adequate oversight and compliance with regulatory requirements for clinical trials, including proper dosing and timely reporting of serious adverse events.
ID · 7fdeaccd-a994-41aa-ba22-314094c5ba1c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.